Amgen's Repatha) Approved in Japan as First PCSK9 Inhibitor for Treatment of High Cholesterol
January 22, 2016 at 04:21 AM EST
Amgen (NASDAQ: AMGN) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering ...
